Measurement of indocyanine green plasma disappearance rate by two different dosages

Autor Sakka, S, Koeck, H, Meier-Hellmann, A
Vydáno 2004

Prognostic value of indocyanine green-plasma disappearance rate in critically ill patients

Autor Sakka, SG, Meier-Hellmann, A, Reinhart, K
Vydáno 2002

Usefulness of intrathoracic blood volume in the early phase of hemodynamic instability of patients with sepsis or septic shock

Autor Sakka, SG, Meier-Hellmann, A, Reinhart, K
Vydáno 1999

Assessment of intrathoracic blood volume and extravascular lung water by single transpulmonary thermodilution

Autor Sakka, SG, Meier-Hellmann, A, Reinhart, K
Vydáno 1999

Procalcitonin — A new indicator of the systemic response to severe infections

Autor Karzai, W., Oberhoffer, M., Meier-Hellmann, A., Reinhart, K.
Vydáno v Infection (1997)

Leukemia and risk of recurrent Escherichia coli bacteremia: genotyping implicates E. coli translocation from the colon to the bloodstream

Autor Samet, A., Śledzińska, A., Krawczyk, B., Hellmann, A., Nowicki, S., Kur, J., Nowicki, B.
Vydáno 2013

A new questionnaire to determine the effect of team interaction in the ICU on perceived futility and intention to quit: results of a pilot study in two German hospitals

Autor Schwarzkopf, D, Bloos, F, Meier-Hellmann, A, Icke, C, Riedemann, N, Hartog, CS
Vydáno 2014

Reversal of oral anticoagulation with prothrombin complex concentrate (Octaplex)

Autor Riess, H, Meier-Hellmann, A, Motsch, J, Elias, M, Kursten, F, Dempfle, C
Vydáno 2007

Increased monocyte activation and tissue factor expression in patients with sepsis

Autor Dohrn, B, Russwurm, S, Vickers, J, Meier-Hellmann, A, Spangenberg, P, Lösche , W, Reinhart, K
Vydáno 1998

Platelets and platelet-activating factor acetylhydrolase in septic patients

Autor Ruβwurm, S, Dohrn, B, Oberhoffer, M, Meier-Hellmann, A, Krause, S, Lösche, W, Reinhart, K
Vydáno 1999

A randomized comparison of two prophylaxis regimens and a paired comparison of on-demand and prophylaxis treatments in hemophilia A management

Autor VALENTINO, L A, MAMONOV, V, HELLMANN, A, QUON, D V, CHYBICKA, A, SCHROTH, P, PATRONE, L, WONG, W-Y
Vydáno 2012

A multicenter randomized controlled study of an extracorporeal cytokine hemoadsorption device in septic patients

Autor Schädler, D, Porzelius, C, Jörres, A, Marx, G, Meier-Hellmann, A, Putensen, C, Quintel, M, Spies, C, Engel, C, Weiler, N, Kuhlmann, M
Vydáno 2013

Clinical assessment of Optivate(®), a high‐purity concentrate of factor VIII with von Willebrand factor, in the management of patients with haemophilia A

Autor DMOSZYNSKA, A., KULICZKOWSKI, K., HELLMANN, A., TRELINSKI, J., KLOCZKO, J., BAGLIN, T., HAY, C., O’SHAUGHNESSY, D., ZAWILSKA, K., MAKRIS, M., SHAIKH‐ZAIDI, R., GASCOIGNE, E., DASH, C.
Vydáno v Haemophilia (2011)

An evaluation of factors predicting long-term response to thalidomide in 234 patients with relapsed or resistant multiple myeloma

Autor Hus, I, Dmoszynska, A, Manko, J, Hus, M, Jawniak, D, Soroka-Wojtaszko, M, Hellmann, A, Ciepluch, H, Skotnicki, A, Wolska-Smolen, T, Sulek, K, Robak, T, Konopka, L, Kloczko, J
Vydáno 2004

Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the ENESTfreedom study

Autor Hochhaus, A, Masszi, T, Giles, F J, Radich, J P, Ross, D M, Gómez Casares, M T, Hellmann, A, Stentoft, J, Conneally, E, García-Gutiérrez, V, Gattermann, N, Wiktor-Jedrzejczak, W, le Coutre, P D, Martino, B, Saussele, S, Menssen, H D, Deng, W, Krunic, N, Bedoucha, V, Saglio, G
Vydáno v Leukemia (2017)

Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the European ENEST1st study

Autor Hochhaus, A, Rosti, G, Cross, N C P, Steegmann, J L, le Coutre, P, Ossenkoppele, G, Petrov, L, Masszi, T, Hellmann, A, Griskevicius, L, Wiktor-Jedrzejczak, W, Rea, D, Coriu, D, Brümmendorf, T H, Porkka, K, Saglio, G, Gastl, G, Müller, M C, Schuld, P, Di Matteo, P, Pellegrino, A, Dezzani, L, Mahon, F-X, Baccarani, M, Giles, F J
Vydáno v Leukemia (2016)

Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German I...

Autor Reinhart, K., Brunkhorst, F. M., Bone, H.-G., Bardutzky, J., Dempfle, C.-E., Forst, H., Gastmeier, P., Gerlach, H., Gründling, M., John, S., Kern, W., Kreymann, G., Krüger, W., Kujath, P., Marggraf, G., Martin, J., Mayer, K., Meier-Hellmann, A., Oppert, M., Putensen, C., Quintel, M., Ragaller, M., Rossaint, R., Seifert, H., Spies, C., Stüber, F., Weiler, N., Weimann, A., Werdan, K., Welte, T.
Vydáno 2010

Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment

Autor Gratwohl, A, Pfirrmann, M, Zander, A, Kröger, N, Beelen, D, Novotny, J, Nerl, C, Scheid, C, Spiekermann, K, Mayer, J, Sayer, H G, Falge, C, Bunjes, D, Döhner, H, Ganser, A, Schmidt-Wolf, I, Schwerdtfeger, R, Baurmann, H, Kuse, R, Schmitz, N, Wehmeier, A, Th Fischer, J, Ho, A D, Wilhelm, M, Goebeler, M-E, Lindemann, H W, Bormann, M, Hertenstein, B, Schlimok, G, Baerlocher, G M, Aul, C, Pfreundschuh, M, Fabian, M, Staib, P, Edinger, M, Schatz, M, Fauser, A, Arnold, R, Kindler, T, Wulf, G, Rosselet, A, Hellmann, A, Schäfer, E, Prümmer, O, Schenk, M, Hasford, J, Heimpel, H, Hossfeld, D K, Kolb, H-J, Büsche, G, Haferlach, C, Schnittger, S, Müller, M C, Reiter, A, Berger, U, Saußele, S, Hochhaus, A, Hehlmann, R
Vydáno v Leukemia (2016)